What is Spinal Cord Stimulation?
Spinal Cord Stimulation (or SCS therapy) is a safe and effective treatment that has been in use for over 55 years.¹ SCS therapy uses a small implantable device to deliver tiny electrical pulses to your spinal cord. These pulses interrupt your body’s pain signals to reduce the sensation of pain before they travel up your spinal cord and reach your brain.

The Evoke® System was approved by the FDA based on the most rigorous clinical study in the history of spinal cord stimulation of 134 patients. Saluda Medical’s Evoke® SCS System delivered pain relief and clinically superior therapy.³ The EVOKE Study reported industry-leading quality of life outcomes, when compared to current SCS systems, and with 3-year data, has the longest follow-up evidence from a randomized clinical study in spinal cord stimulation.²

• 93% Patient satisfaction²
• 83% experienced long-term pain relief
• 55% voluntarily reduced or eliminated their opioid use
• 85% improved ability to perform daily activities
• More than two-thirds showed clinically significant mood improvements
• You can drive with this device in accordance with the patient manual*
• 68% showed clinically significant improvements in sleep time and quality
• Evoke® patients gained on average an additional 1.2 hours of sleep per night

You are able to trial the Evoke® System before deciding to get a permanent implant.

• Leads are placed inside your body near your spinal cord in the epidural space and an external pulse generator is taped to your skin.
• Your health care team establishes your baseline stimulation level.
• You receive instructions about how to use the wireless remote control and how to track your comfort during the trial, as well as any restrictions or limitations during the trial.
• It may take time for your body to adjust to Evoke®, but some patients report feeling pain relief right away!

At home

• You will document how you’re feeling.
• You will receive calls from your care team throughout your trial to help optimize your experience.
• You will track your pain relief and functional improvement throughout the trial.

¹Erkan K, Robin Noordhof RK, van Dongen R, et al. Spinal Cord Stimulation in Failed Back Surgery Syndrome: An Integrative Review of Quantitative and Qualitative Studies. Neuromodulation. 2022; 25: 657-670.

²EVOKE Study 36-month outcomes late-breaker presentation, Mekhail N, NANS 2023. Mekhail, N; On behalf of EVOKE Study Investigators. ECAP-Based SCS for the Treatment of Chronic Pain: Crossover and 36-Month EVOKE Study Outcomes. Late-Breaking Abstract Poster, Presented at NANS 2023. Data on file.

³Mekhail N, Levy RM, Deer TR, et al. Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomised, controlled trial. Lancet Neurol. 2020;19(2):123-34. PMID: 31870766.